Research Edition
Arterial analysis software with innovative additional features for research and studies
Research Edition
Arterial analysis software with innovative additional features for research and studies
.png)
Website Not Compatible with Internet Explorer
Enabling Precision Medicine for Cardiovascular Disease
FDA-cleared and CE-marked cardiovascular diagnostic image analysis software
-
0623T Automated quantification and characterization of coronary atherosclerotic plaque to assess severity of coronary disease, using data from coronary computed tomographic angiography; data preparation and transmission, computerized analysis of data, with review of computerized analysis output to reconcile discordant data, interpretation and rep
-
0624T data preparation and transmission
-
0625T computerized analysis of data from coronary computed tomographic angiography
-
0626T review of computerized analysis output to reconcile discordant data, interpretation and report
The only, non-invasive clinical tool for quantitation of Lipid Rich Necrotic Core & uniquely validated against histopathology
Developed & validated against live tissue specimens
Informing Stoke Risk & Treatment Determination
Baseline
One Year Follow Up After Biologic Therapy
Measuring Therapeutic Response
“Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-Rich Necrotic Core,” Choi et. al. 2020, Circulation
The ElucidVivo Advantage
Accuracy
(1)
standard care
ElucidVivo®
1
(1)
-
Over 40% improvement in stroke prediction accuracy over stenosis-based guidelines
-
Over 30% improvement in MACE prediction accuracy over current standard of care
(2)
1. As presented at Society for Vascular Surgery conference 2020, "CRISP" trial interim results
2. “Automated plaque analysis for the prognostication of major adverse cardiac events” European Journal of Radiology
Cost-Effectiveness
(1)
standard care
ElucidVivo®
-
Reimbursement for both workflows
-
Reduction in unnecessary, invasive diagnostics that do not need to intervention
(1) Potential after 1 year when compared to standard care for total health care system due to better outcomes, reduction in overtreatment, and increased provider efficiency
Experience
standard care
ElucidVivo®
-
Increased provider efficiency through easy-to-digest chart and narrative reports
-
On-premise software analyzes in minutes
-
Better informed decision-making to improve patient outcomes
-
Non-invasive procedure reduces patient burden & time spent in facility
plaque morphology software
atherosclerotic plaque software
high-risk plaque software
plaque quantification software
atherosclerotic plaque quantification software
.png)
Research Edition
Arterial analysis software with innovative additional features for research and studies
high-risk plaque software
